Previous 10 | Next 10 |
2023-11-08 16:13:08 ET The Allure of Penny Stocks Let’s talk about penny stocks , those underdog shares that could either skyrocket or plummet before you’ve finished your coffee. They’re the ones your friend brags about at parties, boasting about turning poc...
2023-11-08 12:23:00 ET DENVER, Colo., Nov. 8, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Roblox Corp (NYSE: RBLX), The RealReal Inc (NASDAQ: REAL), MSP Recovery Inc (NASDAQ: LIFW), Senti Biosc...
2023-11-07 12:35:09 ET DENVER, Colo., Nov. 7, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; PaxMedica Inc (NASDAQ: PXMD), Olaplex Holdings Inc (NASDAQ: OLPX), Hims & Hers Health Inc (NYSE...
2023-11-07 09:58:32 ET DENVER, Colo., Nov. 7, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; PaxMedica Inc (NASDAQ: PXMD), Olaplex Holdings Inc (NASDAQ: OLPX), Hims & Hers Health Inc (NYSE: HIMS), Th...
2023-11-07 09:36:16 ET DENVER, Colo., Nov 7, 2023 ( www.247marketnews.com )- Senti Biosciences Inc. (NASDAQ: SNTI) stated, after yesterday’s market close, that it entered a new strategic collaboration with Celest Therapeutics, a China-based biotechnology company, for the clinical...
2023-11-06 17:21:40 ET More on Senti Biosciences Seeking Alpha’s Quant Rating on Senti Biosciences Historical earnings data for Senti Biosciences Financial information for Senti Biosciences For further details see: Senti stock soars 175% on Chinese...
– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 2024 – – Senti Bio eligible to receive up to $156 million in milestones and royalties – SOUTH SAN ...
– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary Gene Circuit platform – SOUTH SAN FRANCISCO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Senti B...
- Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability of oncology cell therapies - - Abstracts include new preclinical data demonstrating ongoing progress from collaboration with BlueRock Therapeutics and new technology d...
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases using its proprietary Gene Circuit platfor...
News, Short Squeeze, Breakout and More Instantly...
Senti Biosciences Inc. Company Name:
SNTI Stock Symbol:
NASDAQ Market:
Senti Biosciences Inc. Website:
2024-07-18 09:02:04 ET SNTI (SNTI) announced stock split at a ratio of 1-for-10 on 2024-07-18 ... Full story available on KlickAnalytics.com
SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”) , a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that its Board of Directors h...
A look at the top 10 most actives in the United States Zoomcar Holdings Inc. (ZCAR) rose 58.3% to $0.2162 on volume of 130,087,791 shares Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.1863 on volume of 71,767,970 shares SMX (Security Matters) Public Limited Company (SMX) rose 17.1...